AU5680994A - Stabilized catecholamine solutions - Google Patents

Stabilized catecholamine solutions

Info

Publication number
AU5680994A
AU5680994A AU56809/94A AU5680994A AU5680994A AU 5680994 A AU5680994 A AU 5680994A AU 56809/94 A AU56809/94 A AU 56809/94A AU 5680994 A AU5680994 A AU 5680994A AU 5680994 A AU5680994 A AU 5680994A
Authority
AU
Australia
Prior art keywords
stabilized
catecholamine
solutions
catecholamine solutions
stabilized catecholamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU56809/94A
Inventor
Earl R. Speicher
Sandra L Witham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of AU5680994A publication Critical patent/AU5680994A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AU56809/94A 1992-12-10 1993-11-29 Stabilized catecholamine solutions Abandoned AU5680994A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98851292A 1992-12-10 1992-12-10
US988512 1992-12-10
PCT/US1993/011511 WO1994013274A1 (en) 1992-12-10 1993-11-29 Stabilized catecholamine solutions

Publications (1)

Publication Number Publication Date
AU5680994A true AU5680994A (en) 1994-07-04

Family

ID=25534202

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56809/94A Abandoned AU5680994A (en) 1992-12-10 1993-11-29 Stabilized catecholamine solutions

Country Status (2)

Country Link
AU (1) AU5680994A (en)
WO (1) WO1994013274A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740337B1 (en) * 1995-10-27 1997-11-21 Rhone Poulenc Rorer Sa STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING A DERIVATIVE HAVING ADRENERGIC ACTIVITY
FR2740338B1 (en) * 1995-12-01 1997-12-05 Rhone Poulenc Rorer Sa STABILIZED PHARMACEUTICAL COMPOSITIONS CONTAINING DOBUTAMINE
DE19756758C1 (en) * 1997-12-19 1999-08-05 Solvay Pharm Gmbh Stabilized pharmaceutical composition containing dopamine or dobutamine
DE19818802A1 (en) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stable mitoxantron solutions useful for cancer therapy
AU2006203741B2 (en) * 2000-06-06 2009-11-05 Scr Pharmatop Method for obtaining aqueous formulations with active principles susceptible to oxidation and the aqueous solutions thus obtained
FR2809619B1 (en) * 2000-06-06 2004-09-24 Pharmatop NOVEL AQUEOUS FORMULATIONS OF OXIDATION-SENSITIVE ACTIVE INGREDIENTS AND PROCESS FOR OBTAINING THEM
CA2500901A1 (en) * 2002-10-04 2004-04-22 Rinat Neuroscience Corp. Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonists
US8628805B2 (en) 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
SI2437782T1 (en) 2009-06-04 2013-12-31 Alk Ag Stabilised composition comprising at least one adrenergic compound
CN104706572A (en) * 2013-12-14 2015-06-17 山东方明药业集团股份有限公司 Preparation method of dobutamine hydrochloride injection
WO2018140894A1 (en) 2017-01-30 2018-08-02 Nevakar, Inc Norepinephrine compositions and methods therefor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3987200A (en) * 1972-04-12 1976-10-19 Eli Lilly And Company Method for increasing cardiac contractility
DD150694A1 (en) * 1980-04-16 1981-09-16 Gisela Raether METHOD FOR STABILIZING PHARMACEUTICAL PREPARATES WITH OXIDATING SENSITIVITIES

Also Published As

Publication number Publication date
WO1994013274A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
AU4166393A (en) Auto-reclosers
AU5045893A (en) Recessed screw
AU3337193A (en) Telescopic-sight mount
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3803593A (en) Compounds
AU4177593A (en) Benzophenonehydrazones
AU685767B2 (en) Substituted benzazepinones
AU3042892A (en) Rockbolt
AU5680994A (en) Stabilized catecholamine solutions
AU4156393A (en) Heterocyclyltriazolinones
AU5629794A (en) Cryoprotective solutions
AU664253B2 (en) Photo-deviometer
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU5063493A (en) Fitting
AU4604193A (en) Chemical compound
AU4164793A (en) Heterocyclyltriazolinones
AU4632493A (en) Weathershed
AU3048492A (en) New compounds
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4316993A (en) Polyaniles
AU5564794A (en) Play-mark
AU3759793A (en) Compounds